AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
BWX Limitedâs (ASX:BWX) stock sky-rocketed over 30% after the company announced 1H19 revenue of $68.1 million, up from 1.4% on the previous corresponding periodâs revenue of $67.2 million. The stock price has rushed up by 30.435% to last trade at $2.100 on 22 February 2019.
It seems bulls are not affected by as heavy as 51.8% decline in Net Profit After Tax of the company along with downgraded guidance range provided in the First Half Year results of Fiscal 2019. The branded product company revised its FY19 guidance range for underlying EBITDA to $27 million-$29 million which represents an upper range well below the previous guidance range of $27 million-$32 million. The negative change in outlook has been explained as the postponement of several upside initiatives initially planned for 1H19. Â
The upward trend in the companyâs net revenue for 1H19 explains the substantial contribution from retail brands including 182% growth in Andalou Naturalsâ revenue driven by strong North American domestic consumer sales. However, the previous corresponding year included only two months of revenue from Andalou Naturals as it was acquired on 31 October 2017. Its Nourished Life segment has also recorded growth of 53% to $10.4 million revenue in 1H19 on the back of strong domestic growth rate coupled with favourable momentum in the second quarter.
But the Groupâs highest margin brand, Sukin, got significantly impacted by the disruptions faced by the company during the ERP rollout and warehouse relocation in the first half. Positioned as number 1 skincare brand in Australian pharmacy, Sukin has reported a 36% decline to $23.2 revenue in first half of FY19 compared to the previous corresponding period.
BWX Managing Director and Chief Executive Officer, Mr Myles Anceschi, stated that the company has faced several challenges during the half year as it re-set the business. However, there has been a significant turnaround in the second quarter leading to positive momentum in the companyâs transformation plan.
More on numbers front, it can be seen that reported EBITDA of the Group declined by 40.5% to $7.2 million in 1H19, compared to 1H18. Reported NPAT was $2.6 million, a 51.8% decrease on NPAT of the previous corresponding period.
BWXâs Board did not declare any interim dividend for the first half of Fiscal 2019 given the impact on its cash balances as Net Operating Cash Flow declined from $3.7 million in 1H18 to -$7.3 million in 1H19. Reported earnings per share (EPS) also declined by 3.1 cents per share to 2.1 cents for the half year ended 31 December 2018.
Further, the company intends to launch two new international markets in the second half of FY2019 which is expected to further boost the revenue in the period.
BWX last traded at a Price to Earnings multiple of 9.470x with a market capitalisation of $200.04 million. Over the past 12 months, the stock has gone down by 67.54% including a negative performance change of 49.05% over the past three months.
Disclaimer
This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.
